285.5 TWD
4
1.42%
Last update Dec 16, 1:24 PM CST
Market closed
Day range
282.5
290
Previous close
281.5
Open
283.5
Access this stock data via API
Subscribe
Lotus Pharmaceutical Co., Ltd.
285.50
4
1.42%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 4.8B 4.7B 4.7B 4.4B
Cost of revenue 2.0B 2.0B 1.8B 2.0B
Gross profit 2.7B 2.8B 2.9B 2.4B
Operating expense
Research & development 448.0M 164.5M 145.1M 283.1M
Selling general and admin 1.1B 1.1B 1.1B 1.1B
Other operating expenses
Operating income 1.2B 1.5B 1.7B 1.0B
Non operating interest income
Income 27.6M 31.9M 23.2M 30.1M
Expense 126.8M 133.1M 140.8M 139.3M
Other income expense
Pretax income 1.8B 827.3M 1.7B 1.5B
Tax provision 397.6M 99.0M 307.0M 361.8M
Net income 1.4B 728.3M 1.4B 1.1B
Basic EPS 5.5 2.8 5.5
Diluted EPS 5.5 2.8 5.4
Basic average shares 259.4M 259.2M 262.5M
Diluted average shares 260.4M 261.0M 264.1M
EBITDA 2.3B 1.3B 2.2B 2.0B
Net income from continuing op. 1.8B 827.3M 1.7B 1.5B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 10 hours 49 minutes

22:10
00:00
09:00
13:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 13:30
All times are displayed in the Asia/Taipei timezone (CST, UTC+08:00).